Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Bosutinib

    ACTIVE PHARMA INGREDIENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 5,955Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Novartis Scemblix ph III data first to show superior efficacy tolerability
    Novartis Scemblix ph III data first to show superior efficacy tolerability

    03 Jun 2024

    // PHARMABIZ

    https://www.pharmabiz.com/NewsDetails.aspx?aid=169532&sid=2

    PHARMABIZ
    03 Jun 2024
    Share Share
    FDA approves decade-old Pfizer drug for rare childhood leukemia
    FDA approves decade-old Pfizer drug for rare childhood leukemia

    28 Sep 2023

    // Nicole DeFeudis ENDPTS

    https://endpts.com/fda-approves-decade-old-pfizer-drug-for-rare-childhood-leukemia/

    Nicole DeFeudis ENDPTS
    28 Sep 2023
    Share Share
    Amber Specialty Added to Pfizer’s Limited Distribution Network
    Amber Specialty Added to Pfizer’s Limited Distribution Network

    03 Aug 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220803005649/en

    BUSINESSWIRE
    03 Aug 2022
    Share Share
    Novartis investigational STAMP inhibitor asciminib (ABL001) shows superior MMR
    Novartis investigational STAMP inhibitor asciminib (ABL001) shows superior MMR

    08 Dec 2020

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/novartis-investigational-stamp-inhibitor-asciminib-abl001-shows-superior-mmr-rate-to-bosulif-in-chronic-myeloid-leukemia-trial-301188521.html

    PRNEWSWIRE
    08 Dec 2020
    Share Share
    Novartis’ phase III ASCEMBL study of asciminib vs bosutinib meets primary
    Novartis’ phase III ASCEMBL study of asciminib vs bosutinib meets primary

    26 Aug 2020

    // PHARMABIZ

    http://www.pharmabiz.com/NewsDetails.aspx?aid=130660&sid=2

    PHARMABIZ
    26 Aug 2020
    Share Share
    List of Paragraph IV Patent Certifications (PPIV) as of December 3, 2018
    List of Paragraph IV Patent Certifications (PPIV) as of December 3, 2018

    12 Dec 2018

    // FDA

    https://www.fda.gov/downloads/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/ApprovalApplications/AbbreviatedNewDrugApplicationANDAGenerics/UCM293268.pdf

    FDA
    12 Dec 2018
    Share Share